PG490-mediated sensitization of lung cancer cells to Apo2l/TRAIL-induced apoptosis requires activation of ERK2

Oncogene

Volumn 22, Issue 35, 2003, Pages 5427-5435

  Frese, Steffen ^a   Pirnia, Farzaneh ^a   Miescher, Daniela ^a   Krajewski, Stan ^b   Borner, Markus M ^a   Reed, John C ^b   Schmid, Ralph A ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b BURNHAM INSTITUTE   (United States)

Author keywords

Lung cancer; Mitogen activated protein kinase; Primary culture; Resistance to apoptosis; Tumor necrosis factor related apoptosis inducing ligand

Indexed keywords

APOLIPOPROTEIN; CASPASE 3; CASPASE 8; CASPASE 9; CELL SURFACE RECEPTOR; CYCLINE; MITOGEN ACTIVATED PROTEIN KINASE 1; TRIPTERYGIUM WILFORDII EXTRACT; TRIPTOLIDE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; BRONCHUS MUCOSA; CANCER CELL; CANCER PATIENT; COMPETITIVE INHIBITION; CYTOTOXICITY; DRUG EFFECT; ENZYME ACTIVATION; EPITHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG CANCER; PRIORITY JOURNAL; PROTEIN FAMILY; SENSITIZATION; TRADITIONAL MEDICINE;

ANTINEOPLASTIC AGENTS, ALKYLATING; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; DITERPENES; ENZYME ACTIVATION; HUMANS; LUNG NEOPLASMS; MEMBRANE GLYCOPROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 1; PHENANTHRENES; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

BRONCHUS; TRIPTERYGIUM;

EID: 0041333929     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206842     Document Type: Article

References (40)

1. Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, Blackie C, Chang L, McMurtrey AE, Hebert A, DeForge L, Koumenis IL, Lewis D, Harris L, Bussiere J, Koeppen H, Shahrokh Z and Schwall RH. (1999). J. Clin. Invest, 104, 155-162.
2. Chang L and Karin M. (2001). Nature, 410, 37-40.
3. Chang WT, Kang JJ, Lee KY, Wei K, Anderson E, Gotmare S, Ross JA and Rosen GD. (2001). J. Biol. Chem., 276, 2221-2227.
4. Cottom J, Salvador LM, Maizels ET, Reierstad S, Park Y, Carr DW, Davare MA, Hell JW, Palmer SS, Dent P, Kawakatsu H, Ogata M and Hunzicker-Dunn M. (2003). J. Biol. Chem., 278, 7167-7179.
5. English J, Pearson G, Wilsbacher J, Swantek J, Karandikar M, Xu S and Cobb MH. (1999). Exp. Cell Res., 253, 255-270.
6. Evdokiou A, Bouralexis S, Atkins GJ, Chai F, Hay S, Clayer M and Findlay DM. (2002). Int. J. Cancer, 99, 491-504.
7. Faul JL, Nishimura T, Berry GJ, Benson GV, Pearl RG and Kao PN. (2000). Am. J. Respir. Crit. Care Med., 162, 2252-2258.
8. Frese S, Brunner T, Gugger M, Uduehi A and Schmid RA. (2002). J. Thorac. Cardiovasc. Surg., 123, 168-174.
9. Gliniak B and Le T. (1999). Cancer Res., 59, 6153-6158.
10. Greenlee RT, Hill-Harmon MB, Murray T and Thun M. (2001). CA Cancer J. Clin., 51, 15-36.
11. Griffith TS, Fialkov JM, Scott DL, Azuhata T, Williams RD, Wall NR, Altieri DC and Sandler AD. (2002). Cancer Res., 62, 3093-3099.
12. Griffith TS and Lynch DH. (1998). Curr. Opin. Immunol., 10, 559-563.
13. Huynh PN, Hikim AP, Wang C, Stefonovic K, Lue YH, Leung A, Atienza V, Baravarian S, Reutrakul V and Swerdloff RS. (2000). J. Androl., 21, 689-699.
14. Ishiwata N, Jinn Y, Tsukada Y, Inase N, Ichioka M and Yoshizawa Y. (2000). Anticancer Res., 20, 1445-1450.
15. Jo M, Kim TH, Seol DW, Esplen JE, Dorko K, Billiar TR and Strom SC. (2000). Nat. Med., 6, 564-567.
16. Kim Y, Suh N, Sporn M and Reed JC. (2002). J. Biol. Chem., 277, 22320-22329.
17. Kischkel FC, Lawrence DA, Chuntharapai A, Schow P, Kim KJ and Ashkenazi A. (2000). Immunity, 12, 611-620.
18. Krajewska M, Wang HG, Krajewski S, Zapata JM, Shabaik A, Gascoyne R and Reed JC. (1997). Cancer Res., 57, 1605-1613.
19. Lee KY, Chang W, Qiu D, Kao PN and Rosen GD. (1999). J. Biol. Chem., 274, 13451-13455.
20. Lee KY, Park JS, Jee YK and Rosen GD. (2002a). Exp. Mol. Med., 34, 462-468.
21. Lee MW, Park SC, Yang YG, Yim SO, Chae HS, Bach JH, Lee HJ, Kim KY, Lee WB and Kim SS. (2002b). FEBS Lett., 512, 313-318.
22. Lee YJ, Lee KH, Kim HR, Jessup JM, Seol DW, Kim TH, Billiar TR and Song YK. (2001). Oncogene, 20, 1476-1485.
23. Leverkus M, Neumann M, Mengling T, Rauch CT, Brocker EB, Krammer PH and Walczak H. (2000). Cancer Res., 60, 553-559.
24. MacKeigan JP, Collins TS and Ting JP. (2000). J. Biol. Chem., 275, 38953-38956.
25. McCullagh P and Nelder JA. (1989). Monographs on Statistics and Applied Probability, Chapman and Hall, 2nd edition, London.
26. Nam SY, Amoscato AA and Lee YJ. (2002). Oncogene, 21, 337-346.
27. Nesterov A, Ivashchenko Y and Kraft AS. (2002). Oncogene, 21, 1135-1140.
28. Rohn TA, Wagenknecht B, Roth W, Naumann U, Gulbins E, Krammer PH, Walczak H and Weller M. (2001). Oncogene, 20, 4128-4137.
29. Scaffidi C, Schmitz I, Krammer PH and Peter ME. (1999). J. Biol. Chem., 274, 1541-1548.
30. Sprick MR, Weigand MA, Rieser E, Rauch CT, Juo P, Blenis J, Krammer PH and Walczak H. (2000). Immunity, 12, 599-609.
31. Stadheim TA, Xiao H and Eastman A. (2001). Cancer Res., 61, 1533-1540.
32. Tran SE, Holmstrom TH, Ahonen M, Kahari VM and Eriksson JE. (2001). J. Biol. Chem., 276, 16484-16490.
33. Walczak H and Krammer PH. (2000). Exp. Cell Res., 256, 58-66.
34. Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T, Smith C, Smolak P, Goodwin RG, Rauch CT, Schuh JC and Lynch DH. (1999). Nat. Med., 5, 157-163.
35. Wang X, Martindale JL and Holbrook NJ. (2000). J. Biol. Chem., 275, 39435-39443.
36. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C and Smith CA. et al. (1995). Immunity, 3, 673-682.
37. Xia Z, Dickens M, Raingeaud J, Davis RJ and Greenberg ME. (1995). Science, 270, 1326-1331.
38. Xiang H, Fox JA, Totpal K, Aikawa M, Dupree K, Sinicropi D, Lowe J and Escandon E. (2002). Oncogene, 21, 3611-3619.
39. Yang Y, Liu Z, Tolosa E, Yang J and Li L. (1998). Immunopharmacology, 40, 139-149.
40. Zhang XD, Franco A, Myers K, Gray C, Nguyen T and Hersey P. (1999). Cancer Res., 59, 2747-2753.